[go: up one dir, main page]

WO2025079083A1 - Écosystème de gestion de la santé de patients atteints de maladies respiratoires - Google Patents

Écosystème de gestion de la santé de patients atteints de maladies respiratoires Download PDF

Info

Publication number
WO2025079083A1
WO2025079083A1 PCT/IN2024/051945 IN2024051945W WO2025079083A1 WO 2025079083 A1 WO2025079083 A1 WO 2025079083A1 IN 2024051945 W IN2024051945 W IN 2024051945W WO 2025079083 A1 WO2025079083 A1 WO 2025079083A1
Authority
WO
WIPO (PCT)
Prior art keywords
patient
health
platform
module
respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/IN2024/051945
Other languages
English (en)
Other versions
WO2025079083A9 (fr
Inventor
Preetish Mohan TORASKAR
Nandita Sumit DANDEKAR
Ira Preetish TORASKAR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pink Tree Health LLP
Original Assignee
Pink Tree Health LLP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pink Tree Health LLP filed Critical Pink Tree Health LLP
Publication of WO2025079083A1 publication Critical patent/WO2025079083A1/fr
Publication of WO2025079083A9 publication Critical patent/WO2025079083A9/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Measuring devices for evaluating the respiratory organs
    • A61B5/087—Measuring breath flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Measuring devices for evaluating the respiratory organs
    • A61B5/091—Measuring volume of inspired or expired gases, e.g. to determine lung capacity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Measuring devices for evaluating the respiratory organs
    • A61B5/097—Devices for facilitating collection of breath or for directing breath into or through measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring

Definitions

  • the present invention relates to the field of healthcare management. More particularly, the present invention relates to an ecosystem in the form of a phygital (digital+physical) platform to enable the remote monitoring of the progression of different respiratory diseases for individual patients and its effective management.
  • Chronic respiratory diseases and infections are among the most common conditions worldwide. Millions of people are affected with obstructive pulmonary diseases like Tuberculosis, Bronchial asthma, Sleep Apnea and COPD (Chronic obstructive pulmonary disease). The disease condition goes out of control due to ignorance of the symptoms and lack of proper knowledge. It is advantageous for the elderly, the sick and small children to have their lung function monitored for fitness and wellbeing reasons, or when they are in places with high levels of ground ozone, smog, or other air pollutants.
  • the common line of medication includes daily or twice-daily administration of bronchodilator and/or anti-inflammatory medications.
  • Metered dose inhalers are also frequently used to administer these medications by inhalation. But, the overuse of inhalers can lead to potentially fatal adverse effects which include raised blood pressure, cardiac arrest, immune-suppression, caustic damage, and/or tissue scarring. Additionally, excessive use of the inhaler often indicates the need for a more hard-line therapy, like oral administration of corticosteroid; if this need is ignored and the inhaler is still overused, the risk of asthma-related death rises.
  • the need of the hour is to have a common platform which brings the stakeholders such as patient, healthcare professional together to monitor the severe condition of the disease and manage them lung health of the patient proactively to avoid any casualties.
  • the present invention provides a patient health management ecosystem for the remote monitoring of the progression of respiratory diseases.
  • the primary object of the present invention is to provide a respiratory disease related patient health management ecosystem in the form of a phygital platform for the effective management of respiratory diseases.
  • Another object of the present invention is to provide a phygital platform for the regular monitoring of respiratory illness.
  • Yet another object of the present invention is to provide a system to improve quality of life in case of the patients with respiratory diseases.
  • Yet another object of the present invention is to provide a platform for on-time health care professional-patient communication, medication management and involvement of health care providers to ensure optimal health outcomes.
  • Further object of the present invention is to provide a constant intelligent non-intrusive interface between the health care professional and the patient between the two physical visits to avoid the probable casualties.
  • Yet further object of the present invention is to provide a patient educator platform, wherein the patient is guided and supported on a real time basis.
  • Further object of the present invention is to provide a platform where both physical and virtual events are conducted that will have unique objectives of focusing directly or indirectly on respiratory health improvement of the patients.
  • Yet another object of the present invention is to offer an online and offline platform for the patients to attend events related to education, recreation, awareness, competitive, social, or rehabilitation areas for respiratory health management.
  • Yet another object of the present invention is to build a platform to minimize the difficulties and expenses related to hospital visits.
  • Embodiments of the present disclosure may relate to a system and a method of a respiratory disease related patient health management ecosystem in the form of a phygital platform.
  • Embodiments of the present disclosure describes a respiratory disease related patient health management ecosystem in the form of a phygital platform comprising a server with a lung health score calculator, user interface, stakeholders’ modules and testing means.
  • the stakeholders’ modules are made of individual modules for all the stakeholders such as Patient module, health professional module and caregiver module. These modules enable the respective stakeholders to stay connected on this common phygital platform and proactively manage the health status of the lungs.
  • the healthcare professional’s module enables the healthcare professional to take decisions and decide the line of treatment for the particular patient.
  • the Patient’s module needs to be operated by the patient by selecting option for specific disease and undergoing a set of tasks to routinely feed the up-to-date information about the disease conditions by way of testing means which include answering a standardized pre-defined questionnaire and carrying out certain office tests for the specific disease he is suffering from.
  • the caregiver module is provided to aid the disease management of the minors and golden agers.
  • the caregiver follows the line of treatment decided by the healthcare professional.
  • the phygital platform of the present invention is also equipped with a lung health score calculator that helps in calculation of lung health score based on the answers of the questionnaire and the office tests taken by the patient.
  • the respiratory disease related patient health management ecosystem embodies the tasks selected but not limited to Chronic Airways Assessment Test (CAAT), set of questionnaires, record regarding dosage frequency of Short Acting Beta Agonist (SABA) medicine, and common office test including spirometry test.
  • CAAT Chronic Airways Assessment Test
  • SABA Short Acting Beta Agonist
  • the embodiments of the present disclosure encompass a method of managing the respiratory disease using the phygital platform of the said invention comprising of retrieving user data, subjecting the retrieved user data to artificial intelligence, classifying the patients based on the lung health score, transmitting the generated score to the user associated healthcare professional and receiving treatment recommendations based on the generated score.
  • the collected data is mapped with reference to the Aadhar or Abha card of the user.
  • the respiratory disease related patient health management ecosystem tracks parameters like respiratory rate, peak flow parameters, FEV1, etc. on a daily and weekly basis by providing disease specific questionnaires to the user.
  • the respiratory disease related patient health management ecosystem offers a user-friendly home-based medical evaluation to access the status of the respiratory system anytime.
  • FIG. 1 is a realistic representation of the phygital platform of present invention to enable patients focus on their lung health.
  • FIG. 2 is the schematic representation elaborating the object of the phygital platform made available for health professionals, patients and caregivers.
  • FIG. 3 is a schematic representation of the phygital platform described in the present invention.
  • FIG. 4A and 4B depicts the procedural stages of the operation of said phygital platform of the present invention.
  • FIG. 5A to 5D displays the disease specific tests conducted by the patient to determine the lung health score respectively for diseases Asthma, COPD, TB and Sleep Apnea.
  • FIG. 6A to 6G shows graphical representation of the data obtained in a survey conducted to check the preferred choice of the phygital platform by the stakeholder.
  • FIG. 7 depicts a holistic approach of the phygital platform involving all stakeholders keeping the patient in focus.
  • the system in the present invention aims to manage lung health by keeping the patient at the centre of the care. It describes an ecosystem that is built around the patient and has features like personalized care, customized treatment plan taking into consideration the severity level of disease.
  • Respiratory illnesses such as asthma, COPD, Tuberculosis etc. are chronic disorders that affect a staggering population of 358 million people worldwide.
  • the airways of an individual’s lungs constrict in response to specific stimuli. The contraction may occur due to the inflammation of the airways, excessive mucus secretion into the airways, or constriction of the muscles that surround the airways, causing the airways to become narrow.
  • Patients with respiratory illness are prone to acute attacks, which can manifest as tightness in the chest, coughing, wheezing, and shortness of breath.
  • An individual’s oxygen supply may become so severely restricted during severe attacks that they need emergency help.
  • a person usually recovers fully after an acute attack with the right care. Nearly 70% of the total patient population affected with respiratory diseases is struggling to keep the disease under control.
  • bronchodilator and/or anti-inflammatory medications are a common treatment strategy. Metered dose inhalers are frequently used to administer these medications by inhalation.
  • inhalers can lead to potentially fatal adverse effects which include raised blood pressure, cardiac arrest, immune-suppression, caustic damage, and/or tissue scarring. Additionally, excessive use of the inhaler often indicates the need for a more hard-line therapy, like oral administration of corticosteroid; if this need is ignored and the inhaler is still overused, the risk of asthma-related death rises.
  • the present invention tries to offer a solution that addresses all the challenges by providing health professionals with regular updates on patients’ health status fostering continuous connectivity between the visits as shown in FIG. 2,
  • present invention leads to effective disease management for the patient and enhanced patient care for the health professionals.
  • the present invention aims at managing lung health on a universal level.
  • the present invention offers an everyday monitor system in the form of a phygital platform that manages the conditions of respiratory lung health and a method to provide real time insights into a patient’s health.
  • this invention offers a unique phygital experience, blending physical and digital realms to enhance a patient’s health.
  • Various embodiments disclosed herein are directed to the phygital platform of present invention to monitor and manage lung function and respiratory conditions.
  • Embodiments of the present invention describe systems that monitor the frequency and severity of chronic attacks leading to acute pain in the patients with respiratory conditions.
  • these embodiments described herein are contemplated, and intended, for use by individuals of all ages who suffer from asthma or other respiratory conditions and are sensitive to poor air quality and weather conditions.
  • the systems disclosed herein are configured to provide information to health professionals, patients and caregivers in order to improve the personalization of treatment and the predictability of respiratory symptom attacks.
  • COPD chronic obstructive pulmonary disease
  • the present invention is a comprehensive solution based on scientific evidence in the field of respiratory health in the form of a phygital platform for proactive evidence-based disease Management of Patients to be used by healthcare professionals and relevant healthcare stakeholders.
  • Longitudinal data such as clinical, demographic, environmental, socioeconomic etc. is collected from individual patients. Said data is ingested into a statistical model to predict health outcomes for an individual patient suffering from above mentioned respiratory diseases. In this way artificial intelligence through machine learning is employed and used to forecast health events for the patient.
  • Complex technical and scientific data points are transformed into a simple score for healthcare professionals to interpret the dynamic health status of the patient and facilitate him/her to change/continue interventions for better health outcomes. It also acts as a useful aid for healthcare professionals to counsel their patients to understand their health status and adhere/ comply well with the personalized recommendations that are prescribed.
  • said phygital platform (1) operates in the verticals such as pharmacy, pharmaceutical companies, diagnostic laboratories and insurance firms etc., all converging to the common object of creating a throbbing ecosystem which enables the lung health management of the patient.
  • the phygital platform (1) of the present invention enables the patients to update health status on a daily basis.
  • Testing means (400) are provided to aid this.
  • Said testing means (400) include a set of predefined questionnaires (400a) and testing device (400b).
  • the testing means (400) are meant to be disease specific with the help of which disease parameters like respiratory rate, peak flow parameters, FEV1, etc. are tracked on a daily and weekly basis.
  • the patients’ responses to the questionnaire and results of the test are fed to said lung health score calculator (100a) using Al and ML which calculate the lung health score.
  • the data collected is mapped with the Aadhar card or Aabha card of the patient.
  • the present invention describes a phygital platform (1) to monitor and manage asthma as shown in FIG. 5 A.
  • the method of managing patients’ health using said phygital platform between two physical consultations with the healthcare professional involves the following steps:
  • Health status data is received from the asthma patients via patient module (300b) or caregiver via caregiver module (300c) in the form of spirometry test result carried out using testing device (400b) and information based on responses to disease specific standardized questionnaire (400a), this data is stored in the system and analyzed by Al and ML to calculate lung health score (100b) using lung health calculator (100a) which categorizes patients to appropriate zone.
  • the healthcare professional gets notified about the patient zone on the said healthcare professional module (300a) and line of treatment is decided by the healthcare professional and this information is updated in said phygital platform (1).
  • the line of treatment is followed by patients and caregivers to manage the disease conditions.
  • EXAMPLE 2 In this example as shown in FIG. 5B, management of COPD is described.
  • the data of spirometry test carried out using a testing device (400b) and responses of standardized questionnaires (400a) are retrieved, stored, analyzed by Al and ML and lung health score (100b) is generated using lung health calculator (100a).
  • the lung health score (100b) categorizes patients to appropriate zones.
  • the lung score is transmitted to the healthcare professional module (300a) and line of treatment is provided by the healthcare professional based on the zone and the information is updated in said phygital platform (1) and made available to be seen on patient module (300b) and caregiver module (300c).
  • the line of treatment is referred to be followed by the patient or caregiver.
  • BMI index using the specific device (400a) and specific questionnaires (400b) responses for TB are retrieved, stored, analyzed, fed to the lung health score calculator (100a) to calculate the lung health score (100b) is generated.
  • the healthcare professional prescribed the line of treatment to the patient (300b) via said phygital platform (1).
  • the lung score is transmitted to the healthcare professional module (300a) and line of treatment is provided by the healthcare professional based on the zone and the information is updated in said phygital platform (1) and made available to be seen on patient module (300b) and caregiver module (300c).
  • the line of treatment is referred to be followed by the patient or caregiver.
  • FIG. 5D illustrates the management of sleep Apnea by said phygital platform (1).
  • Patient s BMI index responses based on the results of the appropriate testing device (400a) and responses of specific questionnaires (400a), data is retrieved, stored fed to said lung health score calculator (100a) to calculate the lung health score (100b).
  • lung health score calculator 100a
  • the healthcare professional prescribed the line of treatment to the patient via said phygital platform (1).
  • the lung score is transmitted to the healthcare professional module (300a) and line of treatment is provided by the healthcare professional based on the zone and the information is updated in said phygital platform (1) and made available to be seen on patient module (300b) and caregiver module (300c).
  • the line of treatment is referred to be followed by the patient or caregiver.
  • FIG.1 displays the need of the global lung health care using the phygital platform of the present invention i.e. Global lung health management.
  • FIG.2 depicts the real purpose of said phygital platform which is to offer the support to the patient between two physical consultations thereby preventing severities.
  • FIG. 3 is the pictorial representation of the phygital platform displaying its components namely a server, a user interface with lung health score calculator, stakeholders’ modules which are healthcare professional module, a patient module and a caregiver module (in case of minors and golden agers).
  • FIG.4A depicts the entire process flow of the data in the phygital platform of the present invention wherein the Patient regularly checks his health status by answering the standardized questionnaire which will calculate lung health score.
  • FIG. 4B depicts the decision of the line of treatment by the healthcare professional based on the lung score and the zone category decided by said lung health score which is made available on the said platform which is referred to the patient and caregiver.
  • FIG. 5A to 5D displays the disease specific tests conducted by the patient to determine the lung health score respectively for diseases Asthma, COPD, TB and Sleep Apnea.
  • FIG. 6A to 6G shows graphical representation of the data obtained in a survey conducted to check the preferred choice of the phygital platform by the stakeholder.
  • FIG. 7 illustrates futuristic holistic approach involving all stakeholders such as healthcare professionals, hospitals, diagnostic laboratories, pharmaceutical companies, pharmacies, insurance companies keeping the patient in focus. It also indicates the comprehensive lung health solution which aids in better patient management through its unique features. It also indicates strategies and plans of pharma companies prepared for the patient.
  • the present invention provides many advantages, few are listed out below:
  • the present invention provides an ecosystem in the form of a phygital platform for the management of respiratory diseases, by providing a platform for periodical monitoring of clinical parameters that lead to the progression of the diseases.
  • the Ecosystem is an integrated solution to improve respiratory care.
  • the present invention helps in the management of respiratory diseases by improving the adherence rate to therapy by providing support to the patients between two consecutive consultations with his healthcare professionals.
  • the present invention provides an ecosystem that enables the users to easily assess the status of the respiratory diseases anytime.
  • the invention provides a home-based medical evaluation with a connected device that covers the health parameters of the patient voluntarily as well as involuntarily which is converted into analytics by use of Al and Machine learning. Based on the daily analytics received in the app, the healthcare providers can make recommendations.
  • the present invention helps in the constant maintenance of healthcare professional patient interaction and healthcare professionals can prescribe any additional tests based on the report generated.
  • the healthcare providers are thus kept updated regarding the patient's health status.
  • the proposed invention creates an ecosystem around the patient involving clinicians, medical stores, diagnostic labs, insurance, pharma companies, and hospitals ensuring an effective patient support system.
  • the proposed invention reduces the number of hospital visits and associated expenses as early detection of the progression of the diseases is made possible.
  • the proposed invention provides a patient educating platform, wherein the patient will be guided and supported on a real-time basis.
  • the proposed invention provides a platform that conducts events for patients, both physical and virtual, which have unique objectives and focus directly or indirectly on improving respiratory health of the patients. These events could be educational, recreational, awareness, competitive, social, or rehabilitative in nature.
  • the proposed invention yields a patient support system that keeps evaluating/monitoring the respiratory health of patients with the aid of home medical devices, and transfers the information to the AI/ML cloud to analyze and create a unique score for every patient for the day that categorizes the patient into appropriate zones.
  • the red zone indicates the high level of severity
  • yellow zone indicates medium level of severity
  • green zone indicates low level i.e. stable level of disease conditions. This information is shared to the healthcare professional for him to have a view of the respiratory health status of the patients.
  • the interface thus acts as a constant intelligent, non-intrusive interface between the healthcare professional and the patient between the two physical visits.
  • the proposed invention is economically beneficial to the patient in the long run as it may reduce the chances of hospitalization and related expenses.
  • the present invention has been scientifically derived and carefully transformed into a well-crafted technology which requires a combination of technical knowledge and innovative skills.
  • the present invention provides a patient health management ecosystem related to respiratory diseases.
  • the present invention enables collection of longitudinal data from patients which is subjected to artificial intelligence through machine learning and used to forecast health events for the patient.
  • the present invention offers a solution that helps in better disease management for the patient and better patient management for the healthcare professional by maintaining the interaction of healthcare professionals with patients between two consecutive consultations, thus assisting the healthcare professionals to be equipped with the proactive line of treatment.
  • a respiratory disease related patient health management ecosystem in form phygital platform (1) comprising: a) Server (100) with a lung health score calculator (100a) to calculate lung health score (100b); b) User interface (200); c) stakeholder modules (300) wherein said modules (300) include: i) a healthcare professional module (300a) used by healthcare professionals, ii) a patient module (300b) used by patients, iii) a caregiver module (300c) used by caregivers in case of minors and golden agers and d) testing means (400) wherein said testing means (400) includes: i) a predefined set of questionnaires (400a) and ii) testing device (400b) specific to the respiratory disease associated with said patient.
  • testing device (400b) includes common office testing device for conducting tests selected from but not limited to spirometry test, BMI check, activity report, sleep analysis, side effect profile, symptom tracker and medicine tracker.
  • a method of respiratory disease related patient health management ecosystem comprising the steps of: i) retrieving patient data related to clinical parameters associated with a respiratory disease based on disease specific standardized questionnaire (400a); ii) capturing the test results of the tests undergone by the patient from the testing device (400b); iii) feeding the data obtained from the test results and the data based on the answers to standardized questionnaire (400a) to the lung health score calculator (100a) and iv) subjecting it to analysis based on artificial intelligence through machine learning to generate a lung health score (100b) indicative of the user’s respiratory health status; v) classifying the patients based on the lung health score (100b) in specific zones;

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

L'invention concerne un écosystème de gestion de la santé de patients atteints de maladies respiratoires, une plateforme phymérique (1) pour la gestion de maladies respiratoires aiguës et chroniques étant fournie. Ladite plateforme (1) comprend une interface utilisateur (100), un module professionnel de la santé (300a), un module patient (300b) et un module soignant (300c). Elle agit comme une interface constante, intelligente et non intrusive entre le professionnel de la santé et le patient. La santé respiratoire du patient est contrôlée à l'aide d'appareils de test médical à domicile (400b) et de réponses à une série de questionnaires standard (400a). Les informations sont récupérées et analysées quotidiennement par le serveur afin de générer un score de santé pulmonaire qui est transmis au module professionnel de la santé (300a) pour évaluation. En fonction du score de chaque patient, des instructions sont envoyées au module patient (300b) ou au module soignant (300c) pour éviter que les mineurs et les personnes âgées ne soient exposés à un danger mortel.
PCT/IN2024/051945 2023-10-14 2024-10-03 Écosystème de gestion de la santé de patients atteints de maladies respiratoires Pending WO2025079083A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202321069286 2023-10-14
IN202321069286 2023-10-14

Publications (2)

Publication Number Publication Date
WO2025079083A1 true WO2025079083A1 (fr) 2025-04-17
WO2025079083A9 WO2025079083A9 (fr) 2025-05-15

Family

ID=95395242

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2024/051945 Pending WO2025079083A1 (fr) 2023-10-14 2024-10-03 Écosystème de gestion de la santé de patients atteints de maladies respiratoires

Country Status (1)

Country Link
WO (1) WO2025079083A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090105550A1 (en) * 2006-10-13 2009-04-23 Michael Rothman & Associates System and method for providing a health score for a patient
US8684922B2 (en) * 2006-05-12 2014-04-01 Bao Tran Health monitoring system

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8684922B2 (en) * 2006-05-12 2014-04-01 Bao Tran Health monitoring system
US20090105550A1 (en) * 2006-10-13 2009-04-23 Michael Rothman & Associates System and method for providing a health score for a patient

Also Published As

Publication number Publication date
WO2025079083A9 (fr) 2025-05-15

Similar Documents

Publication Publication Date Title
US12451259B2 (en) Apparatus and method for providing healthcare services remotely or virtually with or using an electronic healthcare record and/or a communication network
Hong et al. Effectiveness of tele-monitoring by patient severity and intervention type in chronic obstructive pulmonary disease patients: a systematic review and meta-analysis
US20210295992A1 (en) Fully automated medical solution (mydoctor)
Schlachta-Fairchild et al. Patient safety, telenursing, and telehealth
US20180233237A1 (en) Apparatus and method for processing and/or providing healthcare information and/or healthcare-related information with or using an electronic healthcare record and information regarding and/or obtained with or from electronic interactive activity, information, content, or media
CN112164455B (zh) 一种老年慢性病交互式健康管理系统及其管理方法
US20140067423A1 (en) Apparatus and method for processing and/or providing healthcare information and/or healthcare-related information with or using an electronic healthcare record or electronic healthcare records
CN115116569B (zh) 一种用于提供癌症数字化疾病管理的数字化系统
WO2005122033A1 (fr) Appareil d’information totale médicale et système d’information totale médicale
Titler et al. Cost of care for seniors hospitalized for hip fracture and related procedures
US20220013235A1 (en) Fully autonomous medical solution (mydoctor)
CN110277152A (zh) 基于用户画像的药事服务系统
CN114999631A (zh) 一种基于互联网的智慧医疗系统
KR20080004125A (ko) 원격 검진/건강관리 시스템
Wainwright et al. A review of telemedicine and asthma
WO2025079083A1 (fr) Écosystème de gestion de la santé de patients atteints de maladies respiratoires
WO2006044518A2 (fr) Procede d'identification et d'etablissement de priorites de facteurs de risque modifiables menant a des interventions adaptees aux individus
Kumar et al. Practitioners section-Information and communication technology developments in asthma management: A systematic review
US20250322954A1 (en) Apparatus and method for providing healthcare services remotely or virtually with or using an electronic healthcare record and/or a communication network and/or with or using a personal monitoring device
CN113360847B (zh) 一种心血管疾病预测系统以及包括该预测系统的心血管疾病管理系统
US20250322922A1 (en) Apparatus and method for providing healthcare services remotely or virtually with or using an electronic healthcare record and/or a communication network and/or with or using a personal monitoring device
Razdan Telehealth Interventions in Nursing: Enhancing Patient Care in Rural European Communities
Benech et al. PMU124 patients knowledge on microbiota and acceptability of fecal microbiota transplantation in various chronic diseases
Halpin et al. An Analysis of California Assembly Bill 2185: Mandating Coverage of Pediatric Asthma Self‐Management Training and Education
Irfandi et al. Assessing the Role of Artificial Intelligence in Enhancing Diagnostic Accuracy and Patient Outcomes in Healthcare Systems

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24876841

Country of ref document: EP

Kind code of ref document: A1